UA94085C2 - Pharmaceutical formulation of taxane, solid taxane composition, method for preparing the solid taxane composition and a kit for the injectable taxane formulation - Google Patents

Pharmaceutical formulation of taxane, solid taxane composition, method for preparing the solid taxane composition and a kit for the injectable taxane formulation

Info

Publication number
UA94085C2
UA94085C2 UAA200810530A UAA200810530A UA94085C2 UA 94085 C2 UA94085 C2 UA 94085C2 UA A200810530 A UAA200810530 A UA A200810530A UA A200810530 A UAA200810530 A UA A200810530A UA 94085 C2 UA94085 C2 UA 94085C2
Authority
UA
Ukraine
Prior art keywords
taxane
composition
solid
formulation
free
Prior art date
Application number
UAA200810530A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Антонио Освальдо Боузада
Жозе Луцио Нунез
Жозе Бернардо Итурраспе
Де Итурраспе Нора Адриана Мояно
Original Assignee
Эриошем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эриошем С.А. filed Critical Эриошем С.А.
Publication of UA94085C2 publication Critical patent/UA94085C2/en

Links

Abstract

The invention relates to a taxane pharmaceutical formulation to be administered to mammals, preferably humans, comprising two compositions which are combined prior to administration such as to form a transparent solution free of precipitates, whereby said compositions comprise a lyophilised solid taxane composition free of surfactants, oils, polymers, solubility enhancers, preservatives and excipients, and a composition for solubilising said lyophilised solid taxane composition, containing at least one surfactant. Said formulation is free of polysorbate 80 and polyoxyethylated castor oil. The invention also relates to a method for preparing the solid composition, comprising the lyophilisation of taxane in an organic lyophilisation solvent. The invention further relates to a kit for the injectable taxane formulation, containing a pre-filled syringe, and a pharmaceutical taxane perfusion solution that is free of organic solvent.
UAA200810530A 2006-01-20 2007-01-18 Pharmaceutical formulation of taxane, solid taxane composition, method for preparing the solid taxane composition and a kit for the injectable taxane formulation UA94085C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP066100208 2006-01-20

Publications (1)

Publication Number Publication Date
UA94085C2 true UA94085C2 (en) 2011-04-11

Family

ID=50831838

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200810530A UA94085C2 (en) 2006-01-20 2007-01-18 Pharmaceutical formulation of taxane, solid taxane composition, method for preparing the solid taxane composition and a kit for the injectable taxane formulation

Country Status (2)

Country Link
CR (2) CR10221A (en)
UA (1) UA94085C2 (en)

Also Published As

Publication number Publication date
CR10222A (en) 2008-11-07
CR10221A (en) 2008-11-07

Similar Documents

Publication Publication Date Title
MX2008009358A (en) Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation.
AR110986A2 (en) ECTEINASCIDINE COMPOSITIONS, LIOFILIZED FORMULATIONS, METHOD OF PREPARATION AND USE
AR073123A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTANTIALLY AMORFO TAXANE TO BE USED IN THE TREATMENT OF NEOPLASIC DISEASE
JP2009523770A5 (en)
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
ECSP078023A (en) ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID
TN2009000124A1 (en) Injectable depot composition and its process of preparation
CO6331301A2 (en) COMBINATIONS AND METHODS FOR SUBCUTANEOUS IMMUNOGLOBULIN AND HIALURONIDASE ADMINISTRATION
ECSP088240A (en) COMPOSITION OF TRAZODONE FOR ADMINISTRATION ONCE A DAY
BR112012002709A2 (en) controlled release formulations of lipocalin muteins
BR112015019657A2 (en) topical compositions and methods of use thereof
NZ595445A (en) Insulin formulations for rapid uptake
BR112012033077B8 (en) PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION, USE OF A PHARMACEUTICAL COMPOSITION, AND, KIT
ATE494889T1 (en) PHARMACEUTICAL COMBINATION WITH 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL AND PARACETAMOL
ES2554245T3 (en) Injectable parasiticidal formulations of levamisole and macrocyclic lactones
BR112015020707A2 (en) transdermal formulations
RU2013126259A (en) PHARMACEUTICAL COMPOSITION OF TAXOIDS
AR072333A1 (en) TAXOID BASED INJECTABLE COMPOSITIONS
WO2008116004A3 (en) Transdermal patch and method for delivery of vitamin b12
PE20010407A1 (en) PHARMACEUTICAL FORMULATION IN HYDROXYPROPYL METHYLCELLULOSE CAPSULES
AR063111A1 (en) A PHARMACEUTICAL FORMULATION OF TAXANO
UA94085C2 (en) Pharmaceutical formulation of taxane, solid taxane composition, method for preparing the solid taxane composition and a kit for the injectable taxane formulation
AR045996A1 (en) SEMI-SOLID FORMULATIONS FOR ORAL ADMINISTRATION OF TAXOIDS
PE20130782A1 (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME
EP2525819A4 (en) Immunotherapy compositions and methods of treatment